Jeffrey R. Jay is a healthcare-focused investor who specializes in private equity growth buy-outs and public life sciences strategies. See contact routes.
Jeffrey R. Jay is a healthcare-focused investor who specializes in private equity growth buy-outs and public life sciences strategies within the biopharmaceutical services, medical device contract manufacturing, and healthcare IT sectors. His firm, Great Point Partners, targets lower middle-market companies with a focus on pharma/biotech services and contract manufacturing, having deployed over $5 billion in equity capital across 200+ investments throughout his career. Notable portfolio companies include Eon Labs (acquired by Novartis), AdvancePCS, Cytovance Biologics, and Zura Bio, where he led or supported platform and tuck-in acquisitions to drive innovation. Jay’s distinctive thesis combines deep clinical expertise (as an M.D.) with operational guidance to support profitable healthcare companies, emphasizing asymmetric risk-reward opportunities in complex healthcare landscapes.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Greenwich when building a target list.
Investors like Jeffrey R. Jay · Full investor directory · Investor access · Company funding database